Longeveron (LGVN) Other Operating Expenses (2020 - 2024)
Longeveron's (LGVN) quarterly Other Operating Expenses came in at -$100000.0 in Q3 2024, down 281.82% year-on-year from $55000.0 in Q4 2023, and little changed quarter-over-quarter from -$100000.0 in Q2 2024.
Longeveron (LGVN) Other Operating Expenses (2020 - 2024) Analysis & Trends
Longeveron's Other Operating Expenses history runs 5 years deep, the most recent figure standing at -$100000.0 for Q3 2024.
- On a quarterly basis, Other Operating Expenses fell 281.82% year-over-year to -$100000.0 in Q3 2024; TTM through Jun 2025 was -$100000.0, a 122.22% decrease from a year earlier, with the FY2025 full-year figure at -$97000.0, changed N/A from the prior year.
- Other Operating Expenses held at -$100000.0 in Q3 2024 per LGVN's latest filing, from -$100000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $7.0 million in Q4 2021 and bottomed at -$1.4 million in Q2 2022.
- The 5-year median for Other Operating Expenses is $288000.0 (2020), against an average of $913437.5.
- Across the five-year window, Other Operating Expenses jumped 250.09% in 2021 and plunged 281.82% in 2024, its largest moves.
- Year by year, Other Operating Expenses stood at $2.5 million in 2020, then soared by 174.66% to $7.0 million in 2021, then plunged by 95.91% to $285000.0 in 2022, then sank by 80.7% to $55000.0 in 2023, then plunged by 281.82% to -$100000.0 in 2024.
- Per Business Quant, the three latest LGVN Other Operating Expenses figures stand at -$100000.0 (Q3 2024), -$100000.0 (Q2 2024), and $55000.0 (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Longeveron | 3.97 Mn | -11.79 Mn | 264,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -100,000.00 |
| Jun 30, 2024 | -100,000.00 |
| Sep 30, 2023 | 55,000.00 |
| Jun 30, 2023 | 80,000.00 |
| Dec 31, 2022 | 285,000.00 |
| Sep 30, 2022 | -57,000.00 |
| Jun 30, 2022 | -1.40 Mn |
| Mar 31, 2022 | 287,000.00 |
| Dec 31, 2021 | 6.96 Mn |
| Sep 30, 2021 | 2.05 Mn |
| Jun 30, 2021 | 1.96 Mn |
| Mar 31, 2021 | 550,000.00 |
| Dec 31, 2020 | 2.53 Mn |
| Sep 30, 2020 | 585,000.00 |
| Jun 30, 2020 | 642,000.00 |
| Mar 31, 2020 | 289,000.00 |